Wumatech (ISPR.US/ISPIRE) releases financial performance for FY 2023.
According to the performance report, ISPIRE’s revenue for the fiscal year 2023 increased by 31.2%, reaching $115.6 million. Out of this total:
The revenue from CBD vaporization products has seen a remarkable growth of 100.4%, reaching $40 million. On the other hand, the revenue from e-cigarette products has grown by 10.9%, amounting to $75.6 million.
ISPIRE projects potential growth for its CBD vaporization business to be between 100% and 125% in the fiscal year 2024. Meanwhile, the potential growth for its e-cigarette products is estimated to be between 25% and 40%.
Note: ISPIRE’s fiscal year ends on June 30, 2023.
